conference call scheduled for 9 am EST for DNDN and its commercialization efforts and EU presence....lets hope there is good news, not only for benefit of DNDN investors here, but also we need good fortune in this biotech space to lift OGXI.
My view is that EU will approve Provenge sooner or later, but its all about successful commercialization in NA and EU.
So DNDN is going to Europe on its own it would appear.
Question: name one country in the world that allows doctors to get incentive payments for prescribing drugs? It is the USA. So why does Gold state he believes sales in Europe will be on par with US? Will European doctors prescribe Provenge? How many countries in Europe will pay for it. I bet you the UK won't. Canada won't.
I think commercialization then sales will create some roadblocks to DNDN getting its market cap beyond its present value. I don't mind being wrong because what is good for DNDN is good for OGXI.